🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care

Recruitingn/aAges 18 Years - anyAllThomas Jefferson University
NCT07352579 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study aims to identify the factors that influence whether cancer patients accept or decline supportive care services after screening positive for health-related social needs (HRSNs) at the Sidney Kimmel Comprehensive Cancer Center. The study focuses on adult oncology patients who previously reported at least one HRSN-such as transportation, food, housing, or utility needs-but declined assistance when it was offered. The main questions it aims to answer are: * What factors shape cancer patients' intentions to use supportive care services for HRSNs? * Why do patients who screen positive for HRSNs choose not to accept help offered by the healthcare system? Participants will: * Complete a one-time electronic survey delivered via MyChart or email. * Optionally participate in a semi-structured Zoom interview (for a subset of 20-30 survey respondents) to explore decision

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study: * Provide informed consent via check box for survey * Provide verbal consent via Zoom for interview * Must be able to read and understand English * Willing to comply with all study procedures and be available for the duration of the study * Patients with existing HRSN data in their EHR that answere4d yes to risk in at least one domain and no to wanting help/follow up Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this study: * If they do not consent * Non-patients with existing HRSN data in their EHR * Individuals unable to complete the survey due to language barriers or other cognitive limitations
💊

What it tests

  • Survey
  • Interview
📍

Where

1 site
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy